SIREN : 434076691
BIOSERV is a French company founded 25 years ago, specialized in the sector Réparation de matériels électroniques et optiques. Based in MORANGIS (91420), this company of category PME shows in 2022 a revenue of 850 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | 849 711 € | 642 236 € | N/C | N/C | N/C | 1 054 269 € | 625 012 € |
| Net income | 150 179 € | 143 677 € | 215 066 € | 77 789 € | 114 126 € | 75 122 € | 45 964 € | 35 055 € | 42 956 € |
| EBITDA | N/C | N/C | 294 816 € | 86 396 € | N/C | N/C | N/C | 50 653 € | 61 208 € |
| Net margin | N/C | N/C | 25.3% | 12.1% | N/C | N/C | N/C | 3.3% | 6.9% |
In 2024, BIOSERV generates positive net income of 150 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 43 k€ -> 150 k€.
150 179 €
The debt ratio (= Financial debt / Equity x 100) stands at 3%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 80%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
3.053%
80.238%
14.8%
In 2024, the debt ratio of BIOSERV (3.05) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of BIOSERV (80.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2022, the repayment capacity of BIOSERV (0.31) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 562.25. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
562.248
In 2024, the liquidity ratio of BIOSERV (562.25) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2022, the interest coverage of BIOSERV (0.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 284 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 135 days. The gap of 149 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow.
0 €
284 j
135 j
0 j
Based on 197 transactions of similar company sales (all years), the value of BIOSERV is estimated at 303 303 € (range 127 743€ - 794 960€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 197 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOSERV with other companies in the same sector:
Voir toutes les statistiques du secteur Réparation de matériels électroniques et optiques
The revenue of BIOSERV in 2022 is 850 k€.
Yes, BIOSERV generated a net profit of 150 k€ in 2024.
The headquarters of BIOSERV is located in MORANGIS (91420), in the department Essonne.
The tax return of BIOSERV is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOSERV operates in the sector Réparation de matériels électroniques et optiques (NAF code 33.13Z). See the 'Sector positioning' section above to compare the company with its competitors.